Cassella James V

CIK 0001353528

Chief Development OfficerDirector

Filings

Latest Feb 20, 2026

Issuers covered

Showing

13 of 13

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Cassella James V. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Cassella James V has filed

Ticker	Issuer	Filings	Last filed
CNCE	Concert Pharmaceuticals, Inc.	7	Mar 6, 2023
TRVI	Trevi Therapeutics, Inc.	6	Feb 20, 2026

13 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Feb 20, 2026	TRVITrevi Therapeutics, Inc.	Holdings only	-	-	-
Feb 20, 2025	TRVITrevi Therapeutics, Inc.	Holdings only	-	-	-
Oct 1, 2024	TRVITrevi Therapeutics, Inc.	Holdings only	-	-	-
Jun 14, 2024	TRVITrevi Therapeutics, Inc.	Holdings only	-	-	-
Jun 30, 2023	TRVITrevi Therapeutics, Inc.	Holdings only	-	-	-
Mar 6, 2023	CNCEConcert Pharmaceuticals, Inc.	UTender	80,595	-	-
Feb 16, 2023	CNCEConcert Pharmaceuticals, Inc.	SSale	3,762	$8.34	$31,375
Jan 31, 2023	CNCEConcert Pharmaceuticals, Inc.	SSale	10,106	$8.35	$84,385
Jan 9, 2023	CNCEConcert Pharmaceuticals, Inc.	SSale	2,893	$7.25	$20,974
Jun 23, 2022	TRVITrevi Therapeutics, Inc.	Holdings only	-	-	-
Feb 16, 2022	CNCEConcert Pharmaceuticals, Inc.	SSale	3,762	$3.09	$11,625
Feb 1, 2022	CNCEConcert Pharmaceuticals, Inc.	AGrant	75,800	-	-
Jan 7, 2022	CNCEConcert Pharmaceuticals, Inc.	SSale	2,894	$3.19	$9,232

Showing 1-13 of 13

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.